Memantina Flas Normon (Memantine Hydrochloride)

Memantine hydrochloride is a non‑competitive antagonist of NMDA receptors. By blocking the receptor’s ion channel, it limits calcium overload caused by excessive glutamate, thereby reducing excitotoxic damage to brain cells that contributes to dementia progression.

The dosage of Memantina Flas Normon is determined by the prescribing clinician based on the patient’s clinical condition, renal function and tolerability. The prescriber will set the appropriate strength and dosing schedule.

Safety data for memantine in pregnancy and lactation are limited. The product should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To request Memantina Flas Normon, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Memantine belongs to the NMDA‑receptor antagonist class, whereas cholinesterase inhibitors (e.g., donepezil) increase acetylcholine levels. Memantine is typically used in moderate to severe stages, often in combination with a cholinesterase inhibitor, offering a complementary mechanism of neuroprotection.

Store Memantina Flas Normon at temperatures below 25 °C in its original container. Protect the product from moisture, excessive heat and direct sunlight to maintain stability and potency.

Memantina Flas Normon is taken orally, usually with or without food, as directed by the prescriber. The tablet should be swallowed whole with water and not crushed or chewed unless specifically advised.

Serious adverse events, although uncommon, include hallucinations, seizures and severe hypertension. Patients should be monitored for new or worsening neuro‑psychiatric symptoms and any sudden increase in blood pressure.

Memantina Flas Normon is contraindicated in patients with known hypersensitivity to memantine hydrochloride or any of the excipients. Caution is advised for individuals with uncontrolled seizures, severe renal impairment or those taking other NMDA antagonists.